Date | Time | Source | Headline | Symbol | Company |
05/17/2024 | 3:00PM | iHub Newswire | FeaturedMusic Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements | | |
07/01/2020 | 2:35AM | GlobeNewswire Inc. | Curetis N.V. in liquidatie informs on publication of audited FY2019 financial results and annual report | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
04/30/2020 | 1:59AM | GlobeNewswire Inc. | Curetis N.V. in liquidatie informs on delay of publication of audited FY2019 financial results and annual report | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
04/20/2020 | 1:59AM | GlobeNewswire Inc. | Curetis N.V. in liquidatie to announce liquidation distribution in advance and last trading day | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
04/01/2020 | 4:07PM | GlobeNewswire Inc. | Curetis and OpGen Close Business Combination | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
03/30/2020 | 10:50AM | GlobeNewswire Inc. | OpGen Announces Shareholder Approval for Business Combination with Curetis | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
03/25/2020 | 2:59AM | GlobeNewswire Inc. | Curetis N.V. Informs on OpGen’s Fourth Quarter and Full Year 2019 Financial Results and Business Update | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
03/24/2020 | 9:00AM | GlobeNewswire Inc. | OpGen Provides Further Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
03/19/2020 | 9:00AM | GlobeNewswire Inc. | OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
03/16/2020 | 3:01AM | GlobeNewswire Inc. | Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
03/10/2020 | 11:15AM | GlobeNewswire Inc. | Curetis N.V. Updates on OpGen, Inc. Special Shareholders’ Meeting Held on March 10, 2020 | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
03/10/2020 | 9:13AM | GlobeNewswire Inc. | Curetis N.V. Reports Results of the Extraordinary General Meeting Held on March 10, 2020 | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
02/20/2020 | 1:58AM | GlobeNewswire Inc. | Curetis Announces Preliminary, Unaudited 2019 Condensed Combined Key Financials and Provides Business Update | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
02/06/2020 | 1:59AM | GlobeNewswire Inc. | Curetis and Quaphaco Enter into Unyvero Distribution Partnership for Vietnam | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
01/30/2020 | 1:56AM | GlobeNewswire Inc. | Curetis Group Company Ares Genetics and BGI Group Collaborate to Offer Next-Generation Sequencing and PCR-based Coronavirus (... | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
01/27/2020 | 1:53AM | GlobeNewswire Inc. | Curetis to Hold Extraordinary General Meeting on March 10, 2020 | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
01/23/2020 | 3:50AM | GlobeNewswire Inc. | Curetis To Attend Key Conferences in the First Half of 2020 | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
01/14/2020 | 1:58AM | GlobeNewswire Inc. | Curetis Launches Unyvero LRT Panel for BAL Specimens in the U.S. | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
12/20/2019 | 5:32PM | GlobeNewswire Inc. | Curetis Receives U.S. FDA 510(k) Clearance of Unyvero LRT for BAL Specimens | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
12/10/2019 | 1:58AM | GlobeNewswire Inc. | Ares Genetics, a Curetis Group Company, Joins NVIDIA Inception and AWS Activate Programs | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
11/25/2019 | 4:02AM | GlobeNewswire Inc. | Curetis Group Company Ares Genetics Wins MERCUR Innovation Prize | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
11/25/2019 | 2:00AM | GlobeNewswire Inc. | Curetis Expects Near-Term U.S. FDA Decision on 510(k) Clearance of Unyvero LRT for BAL Specimens | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
11/25/2019 | 1:03AM | GlobeNewswire Inc. | Curetis Publishes Third Quarter and 9-Month Business and Financial Update | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
11/14/2019 | 2:00AM | GlobeNewswire Inc. | Curetis Provides Business Update for the First Nine Months of 2019 | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
10/30/2019 | 5:00AM | GlobeNewswire Inc. | Curetis To Attend Key Conferences in the Fourth Quarter of 2019 | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
10/28/2019 | 2:46AM | GlobeNewswire Inc. | Curetis Group Company Ares Genetics Launches AI-powered Molecular Antibiotic Susceptibility Test | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
09/18/2019 | 1:53AM | GlobeNewswire Inc. | Curetis Reports Financial Results for the First Six Months of 2019 | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
09/04/2019 | 6:55AM | GlobeNewswire Inc. | Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
09/04/2019 | 2:24AM | GlobeNewswire Inc. | Curetis and OpGen Enter Into Definitive Agreement to Combine Businesses | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |
08/12/2019 | 1:59AM | GlobeNewswire Inc. | Curetis Retains H.C. Wainwright & Co. as Strategic Advisor | AMEX:CURE | Direxion Daily Healthcare Bull 3X Shares |